Elizabeth A. Cooper

Auckland, AUK 1023, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Ependymomas are cancers of the pre-neural crest/roof plate lineage.

Ependymomas are cancers of the pre-neural crest/roof plate lineage.

Journal: bioRxiv : the preprint server for biology

Published: July 29, 2026

AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation.

AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation.

Journal: Molecular therapy. Oncology

Published: October 05, 2025

Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.

Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.

Journal: Cell communication and signaling : CCS

Published: May 31, 2023

Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue.

Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue.

Journal: Neuro-oncology advances

Published: November 16, 2022

Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug-carrier molecule for the treatment of glioblastoma.

Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug-carrier molecule for the treatment of glioblastoma.

Journal: Chemical biology & drug design

Published: August 03, 2022

Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action.

Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action.

Journal: Molecules (Basel, Switzerland)

Published: November 25, 2021

Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines.

Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines.

Journal: Bioorganic & medicinal chemistry letters

Published: June 13, 2021

The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors.

The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors.

Journal: Frontiers in oncology

Published: January 17, 2021

Heptamethine Cyanine Dye Mediated Drug Delivery: Hype or Hope.

Heptamethine Cyanine Dye Mediated Drug Delivery: Hype or Hope.

Journal: Bioconjugate chemistry

Published: June 13, 2020

PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines.

PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines.

Journal: Bioorganic & medicinal chemistry letters

Published: March 31, 2020

The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell lines.

The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell lines.

Journal: Bioorganic & medicinal chemistry letters

Published: June 05, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026